Table 4.
Model 1: full model with continuous PCL-C Score as outcome (R2 = 0.61) | ||||
---|---|---|---|---|
Coefficient | Standard error | p-value | 95% confidence interval | |
Age at enrollment | −12.34 | 10.58 | 0.25 | [−33.24, 8.57] |
Gender | 0.03 | 1.49 | 0.99 | [−2.93, 2.99] |
Non-white race | 1.44 | 1.19 | 0.23 | [−0.92, 3.81] |
Years since diagnosis | 12.39 | 10.58 | 0.24 | [−8.53, 33.30] |
Education | ||||
< college degree | −0.05 | 1.43 | 0.97 | [−2.88, 2.77] |
College degree | −0.23 | 1.14 | 0.84 | [−2.49, 2.03] |
Annual Income | ||||
<$60k | 2.96 | 1.43 | 0.04 | [0.12, 5.80] |
<$99k | 0.97 | 1.30 | 0.46 | [−1.61, 3.55] |
Married | 2.24 | 1.16 | 0.05 | [−0.05, 4.54] |
Age at diagnosis | 12.33 | 10.57 | 0.25 | [−8.57, 33.22] |
Childhood survivor | −0.28 | 2.58 | 0.92 | [−5.38, 4.83] |
Multiple diagnoses | −1.38 | 1.45 | 0.34 | [−4.25, 1.48] |
Chemotherapy | −0.00 | 1.15 | 0.99 | [−2.27, 2.27] |
Radiation | −0.70 | 1.18 | 0.55 | [−3.04, 1.63] |
Surgery | 1.09 | 1.49 | 0.46 | [−1.85, 4.04] |
ESSI | −2.42 | 1.28 | 0.06 | [−4.96, 0.11] |
CES-D | 4.48 | 1.59 | 0.005 | [1.34, 7.62] |
SF-36 MCS | −0.20 | 0.07 | 0.003 | [−0.33, −0.07] |
IOC PIS | 1.06 | 0.81 | 0.19 | [−0.53, 2.66] |
IOC NIS | 4.21 | 0.77 | 0.000 | [2.69, 5.73] |
Model 2: parsimonious model with continuous PCL-C Score as outcome (R2 = 0.61) | ||||
---|---|---|---|---|
Coefficient | Standard error | p-value | 95% confidence interval | |
Non-white race | 1.31 | 1.11 | 0.24 | [−0.90, 3.51] |
Annual income | ||||
<$60k | 2.75 | 1.27 | 0.03 | [0.24, 5.25] |
<$99k | 0.83 | 1.24 | 0.51 | [−1.62, 3.28] |
Married | 2.22 | 1.07 | 0.04 | [0.11, 4.33] |
ESSI | −2.44 | 1.16 | 0.04 | [−4.73, −0.15] |
CES-D | 4.59 | 1.51 | 0.003 | [1.6, 7.58] |
SF-36 MCS | −0.21 | 0.06 | 0.001 | [−0.33, −0.09] |
IOC PIS | 0.80 | 0.74 | 0.28 | [−0.67, 2.26] |
IOC NIS | 4.17 | 0.72 | 0.00 | [2.75, 5.59] |
Likelihood ratio test of full model compared to parsimonious model: Prob > chi2 = 0.9790 |
Model 3: parsimonious model with bivariate PCL-C Score of 30 or greater as outcome (pseudo R2 = 0.57) | ||||
---|---|---|---|---|
Odds ratio | Standard error | p-value | 95% confidence interval | |
Non-white race | 1.95 | 1.25 | 0.29 | [0.56, 6.84] |
Annual income | ||||
<$60k | 1.61 | 1.22 | 0.53 | [0.36, 7.09] |
<$99k | 1.07 | 0.88 | 0.93 | [0.21, 5.40] |
Married | 1.03 | 0.67 | 0.96 | [0.29, 3.70] |
ESSI | 0.16 | 0.10 | 0.005 | [0.04, 0.58] |
CES-D | 3.35 | 2.73 | 0.14 | [0.68, 16.57] |
SF-36 MCS | 0.91 | 0.04 | 0.03 | [0.84, 0.99] |
IOC PIS | 3.07 | 1.59 | 0.03 | [1.12, 8.47] |
IOC NIS | 14.21 | 8.94 | 0.000 | [4.14, 48.75] |
Model 4: parsimonious model with bivariate PCL-C Score of 38 or greater as outcome (pseudo R2 = 0.61) | ||||
---|---|---|---|---|
Odds ratio | Standard error | p-value | 95% confidence interval | |
Non-white race | 0.62 | 0.58 | 0.61 | [0.10, 3.91] |
Annual income | ||||
<$60k | 21.97 | 25.40 | 0.008 | [2.28, 211.82] |
<$99k | 0.57 | 0.80 | 0.69 | [0.04, 8.94] |
Married | 3.39 | 3.07 | 0.18 | [0.58, 19.97] |
ESSI | 0.81 | 0.75 | 0.83 | [0.13, 5.00] |
CES-D | 5.52 | 5.88 | 0.11 | [0.68, 44.52] |
SF-36 MCS | 0.89 | 0.05 | 0.03 | [0.81, 0.99] |
IOC PIS | 2.98 | 2.13 | 0.13 | [0.73, 12.10] |
IOC NIS | 7.81 | 6.24 | 0.01 | [1.63, 37.38] |
Model 5: parsimonious model with bivariate PCL-C Score of 44 or greater as outcome (pseudo R2 = 0.61) | ||||
---|---|---|---|---|
Odds ratio | Standard error | p-value | 95% confidence interval | |
Non-white race | 2.94 | 3.19 | 0.32 | [0.35, 24.68] |
Annual income | ||||
<$60k | 27.29 | 37.61 | 0.02 | [1.83, 403.37] |
<$99k | 0.86 | 1.67 | 0.94 | [0.02, 39.37] |
Married | 24.02 | 31.93 | 0.02 | [1.78, 325.02] |
ESSI | 2.89 | 3.92 | 0.43 | [0.20, 41.12] |
CES-D | 1.18 | 1.52 | 0.90 | [0.95, 14.68] |
SF-36 MCS | 0.90 | 0.05 | 0.07 | [0.81, 1.01] |
IOC PIS | 6.27 | 6.29 | 0.08 | [0.88, 44.86] |
IOC NIS | 37.09 | 50.88 | 0.008 | [2.52, 545.46] |
Reference groups: annual income: $100k or greater; Education: graduate degree. ESSI, ENRICHD Social Support Instrument; CES-D, Center for Epidemiologic Studies Depressive Symptoms instrument; SF-36 MCS, Mental Component Summary Score; IOC PIS, Impact of Cancer Positive Impact Summary Score; IOC NIS, Impact of Cancer Negative Impact Summary Score.